Table of Contents

2.3 Medical standards for licensing

From 22 June 2022 there have been changes to the fitness to drive criteria for the following conditions:

  • Implantable cardioverter defibrillator (commercial vehicle drivers)
  • Ventricular assist devices (private vehicle drivers)
  • Congenital disorders (private and commercial vehicle drivers)

See Summary of changes and download the fact sheet for more details

2.3.1 Medical criteria

2.3.2 Conditional licences and periodic review

Because many cardiac conditions are stabilised and not cured, periodic review is recommended. In general, the review interval should be a minimum of 12 months unless otherwise recommended by the treating doctor/specialist, taking into consideration the licence type (e.g. commercial versus private vehicle), other health risk factors and how well the underlying illness is managed.

Where a condition has been effectively treated and there is minimal risk of recurrence, the driver may apply for reinstatement of an unconditional licence on the advice of the treating doctor or specialist (in the case of a commercial vehicle driver). Refer to Part A section 4.5. Reinstatement of licences or removal or variation of licence conditions.

Medical standards for licensing – cardiovascular conditions

Health professionals should familiarise themselves with the information in this chapter and the tabulated standards before assessing a person’s fitness to drive.

Condition

Private standards

(Drivers of cars, light rigid vehicles or motorcycles unless carrying public passengers or requiring a dangerous goods driver licence – refer to definition in Table 3)

Commercial standards

(Drivers of heavy vehicles, public passenger vehicles or requiring a dangerous goods driver licence – refer to definition in Table 3)

Ischaemic heart disease

Acute myocardial infarction (AMI)

Refer also to coronary artery bypass grafting and to percutaneous coronary intervention.

Private standards

The person should not drive for at least 2 weeks after an AMI.

A person is not fit to hold an unconditional licence:

  • if the person has had an AMI.

A conditional licence may be considered by the driver licensing authority subject to periodic review, taking into account the nature of the driving task and information provided by the treating doctor as to whether the following criteria are met:

  • it is at least 2 weeks after an uncomplicated AMI; and
  • there is a satisfactory response to treatment; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness).

Fitness thereafter should be assessed in terms of general convalescence.

Commercial standards

The person should not drive for at least 4 weeks after an AMI.

A person is not fit to hold an unconditional licence:

  • if the person has had an AMI.

A conditional licence may be considered by the driver licensing authority subject to annual review, taking into account the nature of the driving task and information provided by the treating specialist as to whether the following criteria are met:

  • it is at least 4 weeks after an uncomplicated AMI; and
  • there is a satisfactory response to treatment; and
  • there is an exercise tolerance ≥ 90% of the age/sex predicted exercise capacity according to the Bruce protocol or equivalent functional exercise test protocol; and
  • there is no evidence of severe ischaemia – that is, less than 2 mm ST segment depression on an exercise ECG or a reversible regional wall abnormality on an exercise stress echocardiogram or absence of a large defect on a stress perfusion scan; and
  • there is an ejection fraction ≥ 40%; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness).
Angina

Private standards

A person with angina, which is usually absent on mild exertion, and who is compliant with treatment may drive without licence restriction and without notification to the driver licensing authority, subject to periodic monitoring.

A person is not fit to hold an unconditional licence:

  • if the person is subject to angina pectoris at rest or on minimal exertion despite medical therapy, or has unstable angina.

A conditional licence may be considered by the driver licensing authority subject to periodic review, taking into account the nature of the driving task and information provided by the treating specialist as to whether the following criteria are met:

  • there is a satisfactory response to treatment; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness).

Commercial standards

A person is not fit to hold an unconditional licence:

  • if the person is subject to angina pectoris.

A conditional licence may be considered by the driver licensing authority subject to annual review, taking into account the nature of the driving task and information provided by the treating specialist as to whether the following criteria are met:

  • either or both:
    • there is an exercise tolerance ≥ 90% of the age/sex predicted exercise capacity according to the Bruce protocol or equivalent functional exercise test protocol;
    • a resting or stress echocardiogram or a myocardial perfusion study, or both, show no evidence of ischaemia; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness).

If myocardial ischaemia is demonstrated, a coronary angiogram may be offered.

A conditional licence may be considered, subject to annual review, if the following criterion is met:

  • the coronary angiogram (invasive or CT) shows lumen diameter reduction < 70% in a major coronary branch, and < 50% in the left main coronary artery.

If the result of the angiogram shows a lumen diameter reduction of ≥ 70% in a major coronary branch and < 50% in the left main coronary artery (or if an angiogram is not conducted), a conditional licence may be considered, subject to annual review, if the following criteria are met:

  • there is an exercise tolerance ≥ 90% of the age/sex predicted exercise capacity according to the Bruce protocol or equivalent functional exercise test protocol; and
  • there is no evidence of severe ischaemia – that is, less than 2 mm ST segment depression on an exercise ECG or a reversible regional wall abnormality on an exercise stress echocardiogram or absence of a large defect on a stress perfusion scan; and
  • there is an ejection fraction ≥ 40%; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness).

The above criteria also apply if an angiogram is not conducted.

Where surgery or percutaneous coronary intervention is undertaken to relieve the angina, the requirements listed in the table apply.

Coronary artery bypass grafting (CABG)

Private standards

The person should not drive for at least 4 weeks after CABG.

A person is not fit to hold an unconditional licence:

  • if the person requires or has had CABG.

A conditional licence may be considered by the driver licensing authority subject to periodic review, taking into account the nature of the driving task and information provided by the treating doctor as to whether the following criteria are met:

  • it is at least 4 weeks after CABG; and
  • there is satisfactory response to treatment; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness); and
  • there is minimal residual musculoskeletal pain after the chest surgery.

Commercial standards

The person should not drive for at least 3 months after CABG.

A person is not fit to hold an unconditional licence:

  • if the person requires or has had CABG.

A conditional licence may be considered by the driver licensing authority subject to annual review, taking into account the nature of the driving task and information provided by the treating specialist as to whether the following criteria are met:

  • it is at least 3 months after CABG; and
  • there is a satisfactory response to treatment; and
  • there is an exercise tolerance ≥ 90% of the age/sex predicted exercise capacity according to the Bruce protocol or equivalent functional exercise test protocol; and
  • there is no evidence of severe ischaemia – that is, less than 2 mm ST segment depression on an exercise ECG or a reversible regional wall abnormality on an exercise stress echocardiogram or absence of a large defect on a stress perfusion scan; and
  • there is an ejection fraction ≥ 40%; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness); and
  • there is minimal residual musculoskeletal pain after the chest surgery.

Percutaneous coronary intervention (PCI)

(e.g. angioplasty/ stent)

Private standards

The person should not drive for at least 2 days after the PCI.

A person is not fit to hold an unconditional licence:

  • if the person requires or has had a PCI.

A conditional licence may be considered by the driver licensing authority subject to periodic review, taking into account the nature of the driving task and information provided by the treating doctor as to whether the following criteria are met:

  • there was no AMI immediately before or after the PCI; and
  • there is a satisfactory response to treatment; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness).

Commercial standards

The person should not drive for at least 4 weeks after the PCI.

A person is not fit to hold an unconditional licence:

  • if the person requires or has had a PCI.

A conditional licence may be considered by the driver licensing authority subject to annual review, taking into account the nature of the driving task and information provided by the treating specialist as to whether the following criteria are met:

  • it is at least 4 weeks after the PCI; and
  • there is a satisfactory response to treatment; and
  • there is an exercise tolerance ≥ 90% of the age/sex predicted exercise capacity according to the Bruce protocol or equivalent functional exercise test protocol; and
  • there is no evidence of severe ischaemia – that is, less than 2 mm ST segment depression on an exercise ECG or a reversible regional wall abnormality on an exercise stress echocardiogram or absence of a large defect on a stress perfusion scan; and
  • there is an ejection fraction ≥ 40%; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness).
Disorders of rate, rhythm and conduction
Atrial fibrillation

Private standards

The non-driving period will depend on the method of treatment – see below.

A person is not fit to hold an unconditional licence:

  • if an episode of fibrillation results in syncope or incapacitating symptoms.

A conditional licence may be considered by the driver licensing authority subject to periodic review, taking into account the nature of the driving task and information provided by the treating doctor as to whether the following criteria are met:

  • there is a satisfactory response to treatment; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness).

The person should not drive for:

  • at least 1 week following percutaneous ablation;
  • at least 1 week following initiation of successful medical treatment;
  • an appropriate time following open chest surgery.

Commercial standards

The non-driving period will depend on the method of treatment – see below.

A person is not fit to hold an unconditional licence:

  • if the person has a history of recurrent or persistent arrhythmia that may result in syncope or incapacitating symptoms.

A conditional licence may be considered by the driver licensing authority subject to annual review, taking into account the nature of the driving task and information provided by the treating specialist as to whether the following criteria are met:

  • there is a satisfactory response to treatment; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness); and
  • appropriate follow-up has been arranged.

The person should not drive for:

  • at least 4 weeks following percutaneous ablation;
  • at least 4 weeks following initiation of successful medical treatment;
  • at least 3 months following open chest surgery.

If the person is taking anticoagulants refer to ‘anticoagulant therapy’.

Paroxysmal arrhythmias

(e.g. supraventricular tachycardia, atrial flutter, idiopathic ventricular tachycardia)

Private standards

A person is not fit to hold an unconditional licence:

  • if there was near or definite collapse.

A conditional licence may be considered by the driver licensing authority subject to periodic review,* taking into account the nature of the driving task and information provided by the treating doctor as to whether the following criteria are met:

  • there is a satisfactory response to treatment; and
  • there are normal haemodynamic responses at a moderate level of exercise; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness).

* Where the condition is considered to be cured, the requirement for periodic review may be waived.

Commercial standards

The non-driving period is at least 4 weeks.

A person is not fit to hold an unconditional licence:

  • if there was near or definite collapse.

A conditional licence may be considered by the driver licensing authority subject to periodic review,* taking into account the nature of the driving task and information provided by the treating specialist as to whether the following criteria are met:

  • there is a satisfactory response to treatment; and
  • there are normal haemodynamic responses at a moderate level of exercise; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness).

The person should not drive for:

  • at least 4 weeks following PCI;
  • at least 4 weeks following initiation of successful medical treatment.

* Where the condition is considered to be cured, the requirement for periodic review may be waived.

Cardiac arrest

Private standards

The person should not drive for at least 6 months following a cardiac arrest.

Limited exceptions apply – see below.*

A person is not fit to hold an unconditional licence:

  • if the person has suffered a cardiac arrest.

A conditional licence may be considered by the driver licensing authority subject to periodic review, taking into account the nature of the driving task and information provided by the treating doctor as to whether the following criteria are met:

  • it is at least 6 months after the arrest; and
  • the cause of the cardiac arrest and response to treatment has been considered; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness).

* A shorter non-driving period may be considered subject to specialist assessment if the cardiac arrest has occurred within 48 hours of an acute myocardial infarction, or if the arrhythmia causing the cardiac arrest has been addressed by radio frequency ablation surgery or by pacemaker implantation.

Commercial standards

The person should not drive for at least 6 months following a cardiac arrest.

A person is not fit to hold an unconditional licence:

  • if the person has suffered a cardiac arrest.

A conditional licence may be considered by the driver licensing authority subject to annual review, taking into account the nature of the driving task and information provided by the treating specialist as to whether the following criteria are met:

  • it is at least 6 months after the arrest; and
  • a reversible cause is identified and recurrence is unlikely; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness).

Cardiac pacemaker

Refer also to ‘implantable cardioverter defibrillator’ if appropriate.

Private standards

The person should not drive for at least 2 weeks after a pacemaker is inserted.

A person is not fit to hold an unconditional licence:

  • if a cardiac pacemaker is required or has been implanted or replaced.

A conditional licence may be considered by the driver licensing authority subject to periodic review, taking into account the nature of the driving task and information provided by the treating doctor as to whether the following criteria are met:

  • it is at least 2 weeks after insertion of the cardiac pacemaker; and
  • there is a satisfactory response to treatment; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness).

Commercial standards

The person should not drive for at least 4 weeks after a pacemaker is inserted.

A person is not fit to hold an unconditional licence:

  • if a cardiac pacemaker is required or has been implanted or replaced.

A conditional licence may be considered by the driver licensing authority subject to annual review, taking into account the nature of the driving task and information provided by the treating specialist as to whether the following criteria are met:

  • it is at least 4 weeks after insertion of the cardiac pacemaker; and
  • the relative risks of pacemaker dysfunction have been considered; and
  • there are normal haemodynamic responses at a moderate level of exercise; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness).
Implantable cardioverter defibrillator (ICD)

Private standards

The non-driving period will depend on the reason for ICD implantation – see below.

A person is not fit to hold an unconditional licence:

  • if the person requires or has had an ICD implanted for ventricular arrhythmias.

A conditional licence may be considered by the driver licensing authority subject to periodic review, taking into account the nature of the driving task and information provided by the treating specialist as to whether the following criteria are met:

  • the ICD has been implanted for an episode of cardiac arrest and the person has been asymptomatic for 6 months; or
  • the ICD has been prophylactically implanted for at least 2 weeks; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness).

A person should not drive:

  • for 2 weeks after a generator change of an ICD;
  • for at least 4 weeks after appropriate ICD therapy associated with symptoms of haemodynamic compromise (if syncopal, refer to ‘syncope’).

Commercial standards

The person should not drive for at least 6 months after the ICD is implanted.

A person is not fit to hold an unconditional licence or a conditional licence:

  • if the ICD was implanted to manage ventricular arrhythmias (secondary prevention).

A conditional licence may be considered by the driver licensing authority subject to annual review, taking into account the nature of the driving tasks and information provided by the treating specialist* as to whether the following criteria are met:

  • the ICD was implanted for primary prevention; and
  • it is at least 6 months after the insertion of the ICD; and
  • there are no episodes of atrial fibrillation; and
  • there are no discharges from the defibrillator; and
  • interrogation of the ICD shows no evidence of anti-tachycardic pacing; and
  • there is an ejection fraction ≥ 40%; and
  • there is an exercise tolerance > 90% of the age/sex predicted exercise capacity according to the Bruce protocol or equivalent functional test protocol; and
  • there is no evidence of severe ischaemia – that is, less than 2mm ST segment depression on an exercise test or reversible regional wall abnormality on an exercise stress echocardiogram or absence of a large defect on a stress perfusion scan; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness).

* The initial assessment is to be performed by the treating electrophysiologist.

ECG changes

Strain patterns, bundle branch blocks, heart block, etc.

Refer also to ‘cardiac pacemaker’.

Private standards

The person should not drive for at least 2 weeks following initiation of treatment.

A person is not fit to hold an unconditional licence:

  • if the conduction defect is causing symptoms.

A conditional licence may be considered by the driver licensing authority subject to periodic review, taking into account the nature of the driving task and information provided by the treating doctor as to whether the following criteria are met:

  • the condition has been treated procedurally or medically for at least 2 weeks; and
  • there is a satisfactory response to treatment; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness).

* Where the condition is considered to be cured, the requirement for periodic review may be waived.

Commercial standards

The person should not drive for at least 3 months following initiation of treatment.

A person is not fit to hold an unconditional licence:

  • if the person has an electrocardiographic abnormality – for example, left bundle branch block, right bundle branch block, pre-excitation, prolonged QT interval or changes suggestive of myocardial ischaemia or previous myocardial infarction.

A conditional licence may be considered by the driver licensing authority subject to annual review, taking into account the nature of the driving task and information provided by the treating specialist as to whether the following criteria are met:

  • all of the following:
  • the condition has been treated procedurally or medically for at least 3 months; and
  • there is a satisfactory response to treatment; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness); or
  • follow-up investigation has excluded underlying cardiac disease.

* Where the condition is considered to be cured, the requirement for periodic review may be waived.

Vascular disease

Aneurysms – abdominal and thoracic

Private standards

The person should not drive for at least 4 weeks after repair.

A person is not fit to hold an unconditional

licence:

  • if the person has an unrepaired aortic aneurysm – thoracic or abdominal.

A conditional licence may be considered by the driver licensing authority subject to periodic review, taking into account the nature of the driving task and information provided by the treating specialist as to whether the following criteria are met:

  • both:
  • it is at least 4 weeks after repair; and
  • the response to treatment is satisfactory, according to the treating vascular surgeon;
  • or
  • in the case of atherosclerotic aneurysm or aneurysm associated with the bicuspid aortic valve, the aneurysm diameter is less than 55 mm; or
  • the diameter is less than 50 mm for all other aneurysms.

Commercial standards

The person should not drive for at least 3 months after repair.

A person is not fit to hold an unconditional licence:

  • if the person has an unrepaired aortic aneurysm – thoracic or abdominal.

A conditional licence may be considered by the driver licensing authority subject to annual review, taking into account the nature of the driving task and information provided by the treating specialist as to whether the following criteria are met:

  • both:
  • it is at least 3 months after repair; and
  • the response to treatment is satisfactory, according to the treating vascular surgeon;
  • or
  • in the case of atherosclerotic aneurysm or aneurysm associated with the bicuspid aortic valve, the aneurysm diameter is less than 55 mm; or
  • the diameter is less than 50 mm for all other aneurysms.
Deep vein thrombosis (DVT)

Private standards

There are no licensing criteria for DVT. For advisory non-driving period following DVT refer to Table 5. Suggested non-driving periods after cardiovascular events or procedures.

For long-term anticoagulation refer to Table 5. Suggested non-driving periods after cardiovascular events or procedures. Refer also to section 2.2.8 in the text.

Commercial standards

There are no licensing criteria for DVT. For advisory non-driving period following DVT refer to Table 5. Suggested non-driving periods after cardiovascular events or procedures.

For long-term anticoagulation refer to Table 5. Suggested non-driving periods after cardiovascular events or procedures. Refer also to section 2.2.8 in the text.

Pulmonary embolism (PE)

Private standards

There are no licensing criteria for PE.

For advisory non-driving period following PE refer to Table 5. Suggested non-driving periods after cardiovascular events or procedures.

For long-term anticoagulation refer to Table 5. Suggested non-driving periods after cardiovascular events or procedures. Refer also to section 2.2.8.

Commercial standards

There are no licensing criteria for PE.

For advisory non-driving period following PE refer to Table 5. Suggested non-driving periods after cardiovascular events or procedures.

For long-term anticoagulation refer to Table 5. Suggested non-driving periods after cardiovascular events or procedures. Refer also to section 2.2.8.

Valvular heart disease

(including treatment with MitraClips, tricuspid clips, transcutaneous aortic valve replacement and transcutaneous pulmonary valve replacement)

Private standards

The person should not drive for at least 4 weeks following valve repair.

A person is not fit to hold an unconditional licence:

  • if the person has symptoms on moderate exertion.

A conditional licence may be considered by the driver licensing authority subject to periodic review, taking into account the nature of the driving task and information provided by the treating doctor as to whether the following criteria are met:

  • there is a satisfactory response to treatment; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness); and
  • there is minimal residual musculoskeletal pain after chest surgery, if required.

Commercial standards

The person should not drive for at least 4 weeks following valve repair.

A person is not fit to hold an unconditional licence:

  • if the person has any history or evidence of valve disease, with or without surgical repair or replacement, associated with symptoms or a history of embolism, arrhythmia, cardiac enlargement, abnormal ECG or high blood pressure; or
  • if the person is taking anticoagulants (a conditional licence may be issued subject to the requirements specified in Table 5. Suggested non-driving periods after cardiovascular events or procedures in relation to anticoagulant therapy).

A conditional licence may be considered by the driver licensing authority subject to annual review, taking into account the nature of the driving task and information provided by the treating specialist as to whether the following criteria are met:

  • the person’s cardiological assessment shows valvular disease of no haemodynamic significance; or
  • all of the following:
  • it is 3 months following surgery and there is no evidence of valvular dysfunction; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness); and
  • there is minimal residual musculoskeletal pain after chest surgery.
Other cardiovascular diseases
Anticoagulant therapy

Private standards

A person on a private vehicle licence may drive without restriction and without reporting to the driver licensing authority, pending periodic review, if:

  • anticoagulation is maintained at the appropriate degree for the underlying condition.

Commercial standards

A person is not fit to hold an unconditional licence:

  • if the person is on long-term anticoagulant therapy.

A conditional licence may be considered by the driver licensing authority subject to annual review, taking into account the nature of the driving task and information provided by the treating specialist as to whether the following criterion is met:

  • anticoagulation is maintained at the appropriate degree for the underlying condition.

Congenital disorders

Refer also to ‘heart failure’, ‘atrial fibrillation’, ‘paroxysmal arrhythmias’, ‘cardiac pacemaker’ and ‘ICD’.

Private standards

A person may drive without restriction and without reporting to the driver licensing authority if they have uncomplicated congenital heart disease and there are no

or minimal symptoms relevant to driving.

A person should not drive for a period of at least 4 weeks after surgery to correct a congenital lesion.

The person should not drive for at least 2 weeks following a

  • percutaneous procedure to treat a congenital lesion.

A person is not fit to hold an unconditional licence:

  • if the person has a complicated congenital heart disorder.

A conditional licence may be considered by the driver licensing authority subject to periodic review, taking into account the nature of the driving task and information provided by the treating specialist as to whether the following criterion is met:

  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness).

Commercial standards

A person should not drive for at least 3 months following surgical treatment for congenital heart disease.

A person should not drive for 4 weeks following a percutaneous intervention for congenital heart disease.

A person is not fit to hold an unconditional licence:

  • if the person has a complicated congenital heart disorder.

A conditional licence may be considered by the driver licensing authority subject to annual review taking into account the nature of the driving task and the information provided by the treating specialist as to whether the following criteria are met:

  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness); and
  • the ejection fraction of the systemic ventricle is greater than 40%; and
  • there is a minor congenital disorder of no haemodynamic significance such as pulmonary stenosis, atrial septal defect, small ventricular septal defect, bicuspid aortic valve, patent ductus arteriosus or mild coarctation of the aorta; or
  • there has been surgical/percutaneous correction of the congenital lesion including atrial septal defect, ventricular septal defect, patent ductus arteriosus, coarctation, pulmonary stenosis, total correction of tetralogy of Fallot, or total correction of transposition of the great arteries, and there are no or minimal symptoms.
Dilated cardiomyopathy

Private standards

A person is not fit to hold an unconditional licence:

  • if the person has a dilated cardiomyopathy.

A conditional licence may be considered by the driver licensing authority subject to periodic review, taking into account the nature of the driving task and information provided by the treating doctor as to whether the following criteria are met:

  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness); and
  • the person is not subject to arrhythmias.

Cardiologist assessment is recommended for complex presentations.

Commercial standards

A person is not fit to hold and unconditional licence:

  • if the person has a dilated cardiomyopathy.

A conditional licence may be considered by the driver licensing authority subject to annual review, taking into account the nature of the driving task and information provided by the treating specialist as to whether the following criteria are met:

  • there is an ejection fraction ≥ 40%; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness); and
  • the person is not subject to arrhythmias.
Hypertrophic cardiomyopathy (HCM)

Private standards

A person is not fit to hold an unconditional licence:

  • if the person has HCM.

A conditional licence may be considered by the driver licensing authority subject to periodic review, taking into account the nature of the driving task and information provided by the treating specialist as to whether the following criteria are met:

  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness); and
  • the person is not subject to arrhythmias or syncope.

Commercial standards

A person is not fit to hold an unconditional licence:

  • if the person has HCM.

A conditional licence may be considered by the driver licensing authority subject to annual review, taking into account the nature of the driving task and information provided by the treating specialist as to whether the following criteria are met:

  • the left ventricular ejection fraction ≥ 40%; and
  • there is an exercise tolerance ≥ 90% of the age/sex predicted exercise capacity according to the Bruce protocol or equivalent functional exercise test protocol; and
  • there is an absence of: a history of syncope; severe left ventricular hypertrophy; a family history of sudden death; or ventricular arrhythmia on Holter testing; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness).

Heart failure

Refer also to ‘ventricular assist devices’.

Private standards

A person is not fit to hold an unconditional licence:

  • if symptoms arise on moderate exertion.

A conditional licence may be considered by the driver licensing authority subject to periodic review, taking into account the nature of the driving task and information provided by the treating doctor as to whether the following criteria are met:

  • there is a satisfactory response to treatment; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness).

Commercial standards

A person is not fit to hold an unconditional licence:

  • if the person has heart failure.

A conditional licence may be considered by the driver licensing authority subject to annual review, taking into account the nature of the driving task and information provided by the treating specialist as to whether the following criteria are met:

  • there is a satisfactory response to treatment; and
  • there is an exercise tolerance ≥ 90% of the age/ sex predicted exercise capacity according to the Bruce protocol or equivalent functional exercise test protocol; and
  • there is an ejection fraction ≥ 40%; and
  • the underlying cause of the heart failure is considered; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness).
Heart transplant

Private standards

The person should not drive for at least 6 weeks post transplant.

A person is not fit to hold an unconditional licence:

  • if the person requires or has had a heart or heart/lung transplant.

A conditional licence may be considered by the driver licensing authority subject to periodic review, taking into account the nature of the driving task and information provided by the treating specialist as to whether the following criteria are met:

  • it is at least 6 weeks after transplant; and
  • there is a satisfactory response to treatment; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness).

Commercial standards

The person should not drive for at least 3 months post transplant.

A person is not fit to hold an unconditional licence:

  • if the person requires or has had a heart or heart/lung transplant.

A conditional licence may be considered by the driver licensing authority subject to annual review, taking into account the nature of the driving task and information provided by the treating specialist as to whether the following criteria are met:

  • it is at least 3 months after transplant; and
  • there is a satisfactory response to treatment; and
  • there is an exercise tolerance ≥ 90% of the age/ sex predicted exercise capacity according to the Bruce protocol or equivalent functional exercise test protocol; and
  • there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness).
Ventricular assist devices (LVAD, BiVAD)

Private standards

A person should not drive for at least 3 months following insertion of a ventricular assist device.

A person is not fit to hold an unconditional licence:

  • if the person requires an LVAD or BiVAD.

A conditional licence may be considered by the driver licensing authority subject to 6-monthly review, taking into account the nature of the driving task and information provided by the treating specialist as to whether the following criteria are met:

  • the device has been in situ for at least 3 months and there have been no equipment problems during the preceding 2 weeks; and
  • anticoagulation is stable as per this standard; and
  • the medical condition is stable and satisfactorily controlled, and there are minimal symptoms relevant to driving (chest pain, palpitations, breathlessness); and
  • the person is confident in relation to all LVAD or BiVAD equipment.

Where there is concern of cognitive or neurological impairment, a practical driver assessment should be conducted (refer to Part A section 2.3.1. Practical driver assessments).

Commercial standards

A person is not fit to hold an unconditional licence or a conditional licence:

  • if the person requires a VAD of any type or an artificial heart.
Hypertension

Private standards

A person is not fit to hold an unconditional licence:

  • if the person has blood pressure consistently > 200 systolic or > 110 diastolic (treated or untreated).

A conditional licence may be considered by the driver licensing authority subject to periodic review, taking into account the nature of the driving task and information provided by the treating doctor as to whether the following criteria are met:

  • the blood pressure is well controlled; and
  • there are no side effects from the medication that will impair safe driving; and
  • there is no evidence of damage to target organs relevant to driving.

Commercial standards

A person is not fit to hold an unconditional licence:

  • if the person has blood pressure consistently > 170 systolic or > 100 diastolic (treated or untreated).

A conditional licence may be considered by the driver licensing authority subject to annual review, taking into account the nature of the driving task and information provided by the treating specialist* as to whether the following criteria are met:

  • the person is treated with antihypertensive therapy and effective control of hypertension is achieved over a 4-week follow-up period; and
  • there are no side effects from the medication that will impair safe driving; and
  • there is no evidence of damage to target organs relevant to driving.

* Ongoing fitness to drive for commercial vehicle drivers may be assessed by the treating GP provided this is mutually agreed by the specialist, GP and driver licensing authority. The initial granting of a conditional licence must, however, be based on information provided by the specialist.

Stroke

Private standards

Refer to section 6. Neurological conditions.

Commercial standards

Refer to section 6. Neurological conditions.

Syncope

Refer also to section 1. Blackouts.

Private standards

The person can resume driving within 24 hours if the episode was vasovagal in nature with a clear-cut precipitating factor (e.g. venesection) and the situation is unlikely

to occur while driving. The driver licensing authority should not be notified.

The person should not drive for at least 4 weeks after syncope due to other cardiovascular causes.

A person is not fit to hold an unconditional licence:

  • if the condition is severe enough to cause episodes of loss of consciousness without warning.

A conditional licence may be considered by the driver licensing authority subject to periodic review, taking into account the nature of the driving task and information provided by the treating doctor as to whether the following criteria are met:

  • the underlying cause has been identified; and
  • satisfactory treatment has been instituted; and
  • the person has been symptom-free for at least 4 weeks.

Commercial standards

The person can resume driving within 24 hours if the episode was vasovagal in nature with a clear-cut precipitating factor (e.g. venesection) and the situation is unlikely to occur while driving. The driver licensing authority should not be notified.

The person should not drive for at least 3 months after syncope due to other cardiovascular causes.

A person is not fit to hold an unconditional licence:

  • if the condition is severe enough to cause episodes of loss of consciousness without warning.

A conditional licence may be considered by the driver licensing authority subject to

annual review, taking into account the nature of the driving task and information provided by the treating specialist as to whether the following criteria are met:

  • the underlying cause has been identified; and
  • satisfactory treatment has been instituted; and
  • the person has been symptom-free for 3 months.

IMPORTANT: The medical standards and management guidelines contained in this chapter should be read in conjunction with the general information contained in Part A of this publication. Practitioners should give consideration to the following:

Licensing responsibility

The responsibility for issuing, renewing, suspending or cancelling a person’s driver licence (including a conditional licence) lies ultimately with the driver licensing authority. Licensing decisions are based on a full consideration of relevant factors relating to health and driving performance.

Conditional licences

For a conditional licence to be issued, the health professional must provide to the driver licensing authority details of the medical criteria not met, evidence of the medical criteria met, as well as the proposed conditions and monitoring requirements. The presence of other medical conditions While a person may meet individual disease criteria, concurrent medical conditions may combine to affect fitness to drive – for example, hearing, visual or cognitive impairment (refer to Part A section 2.2.7. Older drivers and age-related changes and section 2.2.8. Multiple medical conditions).

The nature of the driving task

The driver licensing authority will take into consideration the nature of the driving task as well as the medical condition, particularly when granting a conditional licence. For example, the licence status of a farmer requiring a commercial vehicle licence for the occasional use of a heavy vehicle may be quite different from that of an interstate multiple combination vehicle driver. The examining health professional should bear this in mind when examining a person and when providing advice to the driver licensing authority.

Reporting responsibilities

Patients should be made aware of the effects of their condition on driving and should be advised of their legal obligation to notify the driver licensing authority where driving is likely to be affected. The health professional may themselves advise the driver licensing authority as the situation requires (refer to section 3.3 and step 6).

References and further reading

  1. Charlton, J. L. & Monash University Accident Research Centre. Influence of chronic illness on crash involvement of motor vehicle drivers. (Monash University, Accident Research Centre, 2010).
  2. Chee, J. N. et al. A systematic review of the risk of motor vehicle collision in patients with syncope. Canadian Journal of Cardiology 37, 151–161 (2021).
  3. European Working Group on Driving and Cardiovascular Disease. New standards for driving and cardiovascular diseases. (2013).
  4. Canadian Medical Association. CMA driver’s guide: determining medical fitness to operate motor vehicles. (Joule, 2017).
  5. Atherton, J. J. et al. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: guidelines for the prevention, detection, and management of heart failure in Australia 2018. Heart Lung and Circulation 27, 1123–1208 (2018).
  6. Lovibond, S. W., Odell, M. & Mariani, J. A. Driving with cardiac devices in Australia. Does a review of recent evidence prompt a change in guidelines? Internal Medicine Journal 50, 271–277 (2020).
  7. Watanabe, E., Abe, H. & Watanabe, S. Driving restrictions in patients with implantable cardioverter defibrillators and pacemakers. Journal of Arrhythmia 33, 594–601 (2017).
  8. Boodhwani, M. et al. Canadian Cardiovascular Society position statement on the management of thoracic aortic disease. Canadian Journal of Cardiology 30, 577–589 (2014).
  9. Tan, V. H., Ritchie, D., Maxey, C. & Sheldon, R. Prospective assessment of the risk of vasovagal syncope during driving. JACC: Clinical Electrophysiology 2, 203–208 (2016).
  10. Shen, W. K. et al. 2017 ACC/AHA/ HRS guideline for the evaluation and management of patients with syncope: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society. Circulation 136, e60– e122 (2017).
  11. Moya, A. et al. Guidelines for the diagnosis and management of syncope (version 2009). European Heart Journal 30, 2631– 2671 (2009).
  12. Hanke, J. S. et al. Driving after left ventricular assist device implantation. Artificial Organs 42, 695–699 (2018).
  13. Slaughter, M. S. et al. Advanced heart failure treated with continuous-flow left ventricular assist device. New England Journal of Medicine 361, 2241–2251 (2009).
  14. Singhvi, A. & Trachtenberg, B. Left ventricular assist devices 101: shared care for general cardiologists and primary care. Journal of Clinical Medicine 8, 1720 (2019).